IFNG and neoplasm: PD-1-deficient Tbet+NK1.1− ILCs express higher levels of IFN-γ and granzyme B. Furthermore, in an experimental mouse model of melanoma, PD-1-deficient Tbet+NK1.1− ILCs impaired tumor growth [190].